Last reviewed · How we verify
NCT04049214
Perioperative Mindfulness Proposal
NA trial testing Meditation in Breast Cancer in 24 participants. Currently enrolling.
31 July 2025
Quick facts
| Lead sponsor | Hoag Memorial Hospital Presbyterian |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 31 July 2019 |
| Primary completion | 31 July 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Meditation
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- DCIS — all drugs for DCIS →
Sponsor
Hoag Memorial Hospital Presbyterian
Who can join
18 and older, female only, with Breast Cancer or DCIS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if a regular meditation and breath work practice started before surgery and continued through post-surgical recovery can improve anxiety and pain related to breast cancer and its treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04049214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Meditation
Trials testing the same drug.
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
- NCT07310992 — Effect of Meditation as an Adjunct to Cardiac Rehabilitation · NA · not yet recruiting
- NCT07176013 — Immersive Virtual Reality Meditation in Voice Therapy · NA · enrolling by invitation
- NCT06866288 — Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study · NA · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Hoag Memorial Hospital Presbyterian trials
Trials by the same sponsor.
- NCT06736054 — A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer · Phase 1 · recruiting
- NCT05880394 — Study of Dotatate Imaging in Breast Cancer · Phase 2 · unknown
- NCT04814615 — A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma · Phase 2 · unknown
- NCT04700332 — PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer · Phase 2 · recruiting
- NCT04883814 — 18F-fluoroestradiol (FES) PET/CT for Breast Cancer · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04049214 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hoag Memorial Hospital Presbyterian
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing